Literature DB >> 2702981

Comparison of the effects of flavone acetic acid, fostriecin, homoharringtonine and tumour necrosis factor alpha on colon 38 tumours in mice.

B C Baguley1, S B Calveley, K K Crowe, L M Fray, S A O'Rourke, G P Smith.   

Abstract

Advanced subcutaneous Colon 38 tumours in mice were used for the assessment of activity of a number of anticancer drugs. Activity was measured by histological examination of tumours 24 h after a single dose of the drug and in some cases by tumour growth delay. Agents thought to exert their cytotoxic effect by damaging DNA, including Adriamycin, amsacrine and its analogue CI-921, cyclophosphamide, 5-fluorouracil and methotrexate produced no gross histological changes after 24 h, even though some delayed the growth of subcutaneous tumours. In contrast, flavone acetic acid, fostriecin and homoharringtonine caused extensive necrosis of tumours after 24 h, and each delayed the growth of advanced subcutaneous tumours by at least 10 days when administered as a single dose. The histological effects of flavone acetic acid and fostriecin were indistinguishable from those of recombinant human tumour necrosis factor alpha. It is proposed that histological assay of advanced tumours may provide a useful adjunct to existing methods in screening for antitumour agents with novel mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702981     DOI: 10.1016/0277-5379(89)90018-7

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  18 in total

Review 1.  Temporal aspects of the action of ASA404 (vadimezan; DMXAA).

Authors:  Bruce C Baguley; Dietmar W Siemann
Journal:  Expert Opin Investig Drugs       Date:  2010-11       Impact factor: 6.206

2.  Labeling of oxidizable proteins with a photoactivatable analog of the antitumor agent DMXAA: evidence for redox signaling in its mode of action.

Authors:  Romy Brauer; Liang-Chuan S Wang; See-Tarn Woon; David J A Bridewell; Kimiora Henare; Dieter Malinger; Brian D Palmer; Stefanie N Vogel; Claudine Kieda; Sofian M Tijono; Lai-Ming Ching
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

Review 3.  5,6-dimethylxanthenone-4-acetic acid (DMXAA): a new biological response modifier for cancer therapy.

Authors:  Shufeng Zhou; Philip Kestell; Bruce C Baguley; James W Paxton
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

4.  Neutrophil influx and chemokine production during the early phases of the antitumor response to the vascular disrupting agent DMXAA (ASA404).

Authors:  Liang-Chuan S Wang; Lotte Thomsen; Rachel Sutherland; Charu B Reddy; Sofian M Tijono; Chun-Jen J Chen; Catherine E Angel; P Rod Dunbar; Lai-Ming Ching
Journal:  Neoplasia       Date:  2009-08       Impact factor: 5.715

5.  Serotonin involvement in the antitumour and host effects of flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.

Authors:  B C Baguley; G Cole; L L Thomsen; Z Li
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumours.

Authors:  L M Ching; W R Joseph; L Zhuang; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Experimental solid tumour activity of N-[2-(dimethylamino)ethyl]-acridine-4-carboxamide.

Authors:  B C Baguley; L Zhuang; E Marshall
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Production of tumour necrosis factor-alpha by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).

Authors:  M Philpott; W R Joseph; K E Crosier; B C Baguley; L M Ching
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels.

Authors:  L J Zwi; B C Baguley; J B Gavin; W R Wilson
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

10.  Antitumour responses to flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid in immune deficient mice.

Authors:  L M Ching; W R Joseph; B C Baguley
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.